Invention Grant
- Patent Title: 17-beta HSD1 and STS inhibitors
- Patent Title (中): 17-beta HSD1和STS抑制剂
-
Application No.: US12892351Application Date: 2010-09-28
-
Publication No.: US08435973B2Publication Date: 2013-05-07
- Inventor: Josef Messinger , Heinrich-Hubert Thole , Bettina Husen , Michael Weske , Pasi Koskimies , Lila Pirkkala
- Applicant: Josef Messinger , Heinrich-Hubert Thole , Bettina Husen , Michael Weske , Pasi Koskimies , Lila Pirkkala
- Applicant Address: DE Hannover
- Assignee: Abbott Products GmbH
- Current Assignee: Abbott Products GmbH
- Current Assignee Address: DE Hannover
- Agency: Crowell & Moring LLP
- Main IPC: A61K31/566
- IPC: A61K31/566 ; A61K31/58 ; C07J1/00 ; C07J17/00 ; C07J43/00

Abstract:
Substituted steroid compounds which represent selective inhibitors of 17β-hydroxysteroid dehydrogenase type I (17β-HSD1) and, in addition, which may represent inhibitors of the steroid sulfatase, salts thereof, pharmaceutical preparations containing these compounds, and a process for the preparation of these compounds. Also disclosed is a therapeutic method of using such substituted steroid compounds, particularly in the treatment, inhibition, prophylaxis or prevention of steroid hormone dependent diseases or disorders, such as steroid hormone dependent diseases or disorders requiring the inhibition of 17β-hydroxysteroid dehydrogenase type I and/or steroid sulfatase enzymes and/or requiring lowering of the endogenous 17β-estradiol concentration.
Public/Granted literature
- US20110021480A1 17-beta HSD1 and STS Inhibitors Public/Granted day:2011-01-27
Information query